Skip to main content

VICC limited submission opportunity: V Foundation Immunology or Immunotherapy Award

May. 8, 2017, 10:27 AM

The Vanderbilt-Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2017 Pediatric Cancer Research–Immunology or Immunotherapy Award. The Pediatric Cancer Research–Immunology or Immunotherapy Award is a three-year grant of $200,000 per year.

VICC may nominate one candidate for this award. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than five years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial. A maximum of 10 percent indirect costs (within the award amount) are supported in the award. NIH salary caps are observed.

Applicant eligibility: By the due date of the application, applicants who will lead this research team must have all of the following:

  • Be scientists who hold a faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
  • Applicants must be either U.S. Citizens or have a legal permit to work in the United States (either temporary or permanent).

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. Monday, May 15.

  1. A brief (two-page maximum) research plan including summary budget;
  1. A brief statement of support from the department chair/center director;
  1. A CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email.

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the foundation by the June 2 deadline.

If you have any questions about the foundation or its interests and priorities, please contact Megan Smallwood in the Office of Research or Adele White in the Corporate and Foundation Relations Office.

Recent Stories from VUMC News and Communications Publications

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

more